11-34656955-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_012153.6(EHF):c.592C>A(p.His198Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,488 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012153.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EHF | NM_012153.6 | c.592C>A | p.His198Asn | missense_variant | 7/9 | ENST00000257831.8 | NP_036285.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EHF | ENST00000257831.8 | c.592C>A | p.His198Asn | missense_variant | 7/9 | 1 | NM_012153.6 | ENSP00000257831.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152154Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250632Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135454
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461334Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 726940
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152154Hom.: 1 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.658C>A (p.H220N) alteration is located in exon 7 (coding exon 7) of the EHF gene. This alteration results from a C to A substitution at nucleotide position 658, causing the histidine (H) at amino acid position 220 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at